Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance Via NO-Enhanced Chemosensitization

Overview

Journal ACS Appl Mater Interfaces

Publisher American Chemical Society

Specialties Biomedical Engineering
Biotechnology

Date 2016 May 24

PMID 27213922

Citations 25

Authors

Jing Fan

Qianjun He

Yi Liu

Fuwu Zhang

Xiangyu Yang

Zhe Wang

Nan Lu

Wenpei Fan

Lisen Lin

Gang Niu

Nongyue He

Jibin Song

Xiaoyuan Chen

Affiliations

Soon will be listed here.

Abstract

Multidrug resistance (MDR) is responsible for the relatively low effectiveness of chemotherapeutics. Herein, a nitric oxide (NO) gas-enhanced chemosensitization strategy is proposed to overcome MDR by construction of a biodegradable nanomedicine formula based on BNN6/DOX coloaded monomethoxy(polyethylene glycol)-poly(lactic-co-glycolic acid) (mPEG-PLGA). On one hand, the nanomedicine features high biocompatibility due to the high density of PEG and biodegradable PLGA. On the other hand, the nanoformula exhibits excellent stability under physiological conditions but exhibits stimuli-responsive decomposition of BNN6 for NO gas release upon ultraviolet-visible irradiation. More importantly, after NO release is triggered, gas molecules are generated that break the nanoparticle shell and lead to the release of doxorubicin. Furthermore, NO was demonstrated to reverse the MDR of tumor cells and enhance the chemosensitization for doxorubicin therapy.

Citing Articles

Therapeutic functions of medical implants from various material categories with integrated biomacromolecular systems.

Calais G, Garcia G, de Moura Junior C, Soares J, Lona L, Beppu M Front Bioeng Biotechnol. 2025; 12:1509397.

PMID: 39867472 PMC: 11757644. DOI: 10.3389/fbioe.2024.1509397.

Near-infrared light-responsive Nitric oxide microcarrier for multimodal tumor therapy.

Liang D, Kuang G, Chen X, Lu J, Shang L, Sun W Smart Med. 2024; 2(3):e20230016.

PMID: 39188343 PMC: 11236066. DOI: 10.1002/SMMD.20230016.

A review of advanced hydrogels for cartilage tissue engineering.

Ansari M, Darvishi A, Sabzevari A Front Bioeng Biotechnol. 2024; 12:1340893.

PMID: 38390359 PMC: 10881834. DOI: 10.3389/fbioe.2024.1340893.

Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy.

Wu X, Zhou Z, Li K, Liu S Adv Sci (Weinh). 2024; 11(16):e2308632.

PMID: 38380505 PMC: 11040387. DOI: 10.1002/advs.202308632.

Near Infrared Light-Activatable Platelet-Mimicking NIR-II NO Nano-Prodrug for Precise Atherosclerosis Theranostics.

Chai Y, Shangguan L, Yu H, Sun Y, Huang X, Zhu Y Adv Sci (Weinh). 2023; 11(3):e2304994.

PMID: 38037484 PMC: 10797437. DOI: 10.1002/advs.202304994.

References

Sullivan R, Graham C . Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 2007; 26(2):319-31. DOI: 10.1007/s10555-007-9062-2. View

Pelicano H, Carney D, Huang P . ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7(2):97-110. DOI: 10.1016/j.drup.2004.01.004. View

Fan J, He N, He Q, Liu Y, Ma Y, Fu X . A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO. Nanoscale. 2015; 7(47):20055-62. PMC: 4666708. DOI: 10.1039/c5nr06630a. View

Brown J, Wilson W . Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004; 4(6):437-47. DOI: 10.1038/nrc1367. View

Frederiksen L, Sullivan R, Maxwell L, Macdonald-Goodfellow S, Adams M, Bennett B . Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res. 2007; 13(7):2199-206. DOI: 10.1158/1078-0432.CCR-06-1807. View

Schroeijers A, Scheffer G, Flens M, Meijer G, Izquierdo M, van der Valk P . Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. Am J Pathol. 1998; 152(2):373-8. PMC: 1857981. View

Samadi N, Abbadessa A, Di Stefano A, van Nostrum C, Vermonden T, Rahimian S . The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. J Control Release. 2013; 172(2):436-43. DOI: 10.1016/j.jconrel.2013.05.034. View

Movsas B, Chapman J, Horwitz E, Pinover W, Greenberg R, Hanlon A . Hypoxic regions exist in human prostate carcinoma. Urology. 1999; 53(1):11-8. DOI: 10.1016/s0090-4295(98)00500-7. View

Ridnour L, Isenberg J, Espey M, Thomas D, Roberts D, Wink D . Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci U S A. 2005; 102(37):13147-52. PMC: 1201580. DOI: 10.1073/pnas.0502979102. View

10.

Muir C, Adams M, Graham C . Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells. Breast Cancer Res Treat. 2005; 96(2):169-76. DOI: 10.1007/s10549-005-9076-9. View

11.

Cole S, Deeley R . Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol Sci. 2006; 27(8):438-46. DOI: 10.1016/j.tips.2006.06.008. View

12.

Prasad V, Reddy G, Kathmann I, Amareswararao M, Peters G . Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells. Bioorg Chem. 2015; 64:51-8. DOI: 10.1016/j.bioorg.2015.11.007. View

13.

Zhu H, BUNN H . Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respir Physiol. 1999; 115(2):239-47. PMC: 3045521. DOI: 10.1016/s0034-5687(99)00024-9. View

14.

Yasuda H, Nakayama K, Watanabe M, Suzuki S, Fuji H, Okinaga S . Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. Clin Cancer Res. 2006; 12(22):6748-57. DOI: 10.1158/1078-0432.CCR-06-1124. View

15.

Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M . A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 1996; 56(18):4124-9. View

16.

Brizel D, Sibley G, Prosnitz L, Scher R, Dewhirst M . Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997; 38(2):285-9. DOI: 10.1016/s0360-3016(97)00101-6. View

17.

Grandjean F, Bremaud L, Verdier M, Robert J, Ratinaud M . Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines. Anticancer Drugs. 2001; 12(3):247-58. DOI: 10.1097/00001813-200103000-00010. View

18.

Liao D, Johnson R . Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 2007; 26(2):281-90. DOI: 10.1007/s10555-007-9066-y. View

19.

Chung M, Liu H, Lin K, Chia W, Sung H . A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance. Angew Chem Int Ed Engl. 2015; 54(34):9890-3. DOI: 10.1002/anie.201504444. View

20.

Wink D, Miranda K, Espey M, Pluta R, Hewett S, Colton C . Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal. 2001; 3(2):203-13. DOI: 10.1089/152308601300185179. View